Change Language
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection
Simulect Injection

Simulect Injection

Price 76300.0 INR/ Piece

MOQ : 10 Parcels

Simulect Injection Specification

  • Packaging Type
  • Vial
  • Indication
  • Preventing acute rejection in kidney transplant
  • Brand Name
  • Simulect
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Dosage Form
  • Injection
  • Salt Composition
  • Basiliximab 20 mg
  • Origin of Medicine
  • Switzerland
  • Life Span
  • Check expiry date on the pack
  • Drug Type
  • Biological
  • Ingredients
  • Basiliximab
  • Physical Form
  • Liquid
  • Function
  • Immunosuppressant
  • Recommended For
  • For prevention of acute organ rejection in renal transplant patients
  • Dosage
  • As prescribed by physician
  • Dosage Guidelines
  • Administered intravenously. Follow physician guidance.
  • Suitable For
  • Adults and paediatric patients (age 1-17 years) receiving a kidney transplant
  • Quantity
  • 20 mg/5 ml per vial
  • Storage Instructions
  • Store at 2-8C. Do not freeze.
  • Regulatory Approval
  • US FDA and EMA approved
  • Administration Route
  • Intravenous infusion
  • ATC Code
  • L04AA10
  • Shelf life (unopened)
  • 2 years from manufacturing date
  • Appearance
  • Clear, colourless to slightly yellow solution
  • Contraindications
  • Known hypersensitivity to basiliximab or other mouse-derived proteins
  • Prescription Required
  • Yes
  • Patient Population
  • Renal transplant recipients
  • Special Precautions
  • Monitor for hypersensitivity and infection risk
  • Reconstitution Needed
  • No, ready to use
 

Simulect Injection Trade Information

  • Minimum Order Quantity
  • 10 Parcels
  • Supply Ability
  • 500 Parcels Per Month
  • Delivery Time
  • 7 Days
 

About Simulect Injection

Simulect Injection belongs to the immunosuppressant group of medicines. It regulates the immune system to prevent rejection of the kidney transplantation. It is usually prescribed in combination with some other medicines.

Simulect Injection is a prescription medicine that must be administered by a healthcare professional. You must receive the exact dose of it as per the prescription. An overdose of this medicine may have serious side effects on the body.

The common side effects of this medicine are nausea, vomiting, constipation, etc. It may also cause an injection site reaction (redness, pain, and swelling). The medicine can safely be used in children.

Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease. Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment. During the treatment, your doctor may advise you some laboratory tests to know the effects of the medicine in the body.



Mechanism of Action

Simulect (basiliximab) is a biological immunosuppressant that works by inhibiting the activation of lymphocytes, a type of white blood cell involved in organ rejection. By binding to a specific receptor on these cells, it prevents the immune response that can cause the body to reject a transplanted kidney.


Administration and Dosage

Simulect is given by intravenous infusion as prescribed by your physician, usually around the time of transplantation. Each vial contains 20 mg/5 ml and is ready to use without reconstitution. The dose and schedule may vary depending on the patient's age and clinical condition. Only a healthcare professional should administer Simulect.


Storage and Shelf Life

Store Simulect at 2-8C and do not freeze. The product remains stable for up to two years from the manufacturing date, provided it is kept unopened and proper storage guidelines are followed. Always check the expiry date before use to ensure safety and efficacy.


Safety and Precautions

While Simulect can be highly effective in preventing kidney transplant rejection, it requires medical supervision due to potential risks such as hypersensitivity reactions and increased susceptibility to infection. It is contraindicated for patients with known allergies to basiliximab or mouse-derived proteins.

FAQ's of Simulect Injection:


Q: How is Simulect Injection administered to patients?

A: Simulect is administered as an intravenous infusion, usually in a hospital setting and under the supervision of a healthcare professional. The doctor will determine the appropriate dosage and timing for each patient, often around the time of the kidney transplant procedure.

Q: What is the primary benefit of using Simulect Injection?

A: The main benefit of Simulect is its ability to significantly reduce the risk of acute organ rejection following a kidney transplant. By weakening certain aspects of the immune response, it helps the body accept the new organ and improves transplant success rates.

Q: Who can receive Simulect Injection?

A: Simulect is recommended for both adult and pediatric patients (ages 1-17 years) who are undergoing kidney transplantation. It should not be used in individuals with known hypersensitivity to basiliximab or mouse-derived proteins.

Q: What precautions should be taken during the use of Simulect?

A: Patients receiving Simulect should be closely monitored for signs of hypersensitivity or allergic reactions as well as infection. Administration is performed in a healthcare setting so immediate treatment can be given if adverse effects occur.

Q: When should Simulect Injection not be used?

A: Simulect should not be used in anyone with a known allergy to basiliximab or proteins derived from mice. Inform your healthcare provider if you have any history of such allergies before starting treatment.

Q: Where should Simulect Injection be stored before use?

A: Simulect should be stored in a refrigerator at a temperature between 2C and 8C. Do not freeze the injection and always keep it in its original packaging until use to protect it from light and contamination.

Q: What is the process for receiving Simulect during a kidney transplant?

A: The process involves preparing a single-dose vial before administration, with Simulect infused intravenously on or around the day of the kidney transplant. A repeat dose may be given as prescribed. Healthcare professionals will monitor you closely throughout the process.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Injection Category

Imfinzi 120mg/2.4ml

Imfinzi 120mg/2.4ml

Minimum Order Quantity : 10 Units

Suitable For : Other, Adults only

Salt Composition : Durvalumab 120mg in 2.4ml (50mg/ml)

Physical Form : Other, Liquid Solution

Drug Type : Other, Biological (Monoclonal Antibody)

Novomix 30 Flexpen Biphasic Insulin Aspart

Novomix 30 Flexpen Biphasic Insulin Aspart

Minimum Order Quantity : 500 Pieces

Suitable For : Adults

Salt Composition : Novomix

Physical Form : Liquid

Drug Type : Injection

5 gm Human Normal Immunoglobulin IP

5 gm Human Normal Immunoglobulin IP

Minimum Order Quantity : 500 Pieces

Physical Form : Liquid

Drug Type : Injection

Novoseven 1mg Injection

Novoseven 1mg Injection

Price 47534.0 INR / Unit

Minimum Order Quantity : 1 Unit

Salt Composition : Eptacog alfa (1mg)



Back to top